Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Found 4376 publications
Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016 US$ 3,500.00

... Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) The report reviews Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) targeted therapeutics under development ...

Jul, 2016 160 pages
Myocardial Fibrosis - Pipeline Review, H1 2016 US$ 2,000.00

Myocardial Fibrosis - Pipeline Review, H1 2016 SUMMARY Global Markets Direct’s, ‘Myocardial Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Myocardial Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocardial Fibrosis ...

Jun, 2016 82 pages
Vitae Pharmaceuticals, Inc. (VTAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 20 pages
Vet-Stem - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 14 pages
uniQure N.V. (QURE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 37 pages
Ultragenyx Pharmaceutical Inc. (RARE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 34 pages
UAS Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 16 pages
U.S. HealthWorks Medical Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 46 pages
Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 22 pages
The National Institute of Diabetes and Digestive and Kidney Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... National Institute of Diabetes and Digestive and Kidney Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings ...

Apr, 2015 304 pages
Tetraphase Pharmaceuticals Inc. (TTPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 35 pages
Terpenoid Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 21 pages
TechnoVax, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 19 pages
Targazyme, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 21 pages
SynZyme Technologies, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 17 pages
Syntrix Biosystems, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 35 pages
Syntiron LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 18 pages
Stratatech Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 38 pages
SomaGenics Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 23 pages
Saneron CCEL Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... Saneron CCEL Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings ...

Apr, 2015 20 pages
RxGen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 16 pages
Rusnano JSC - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 38 pages
Reaction Biology Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 21 pages
Purdue University - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 17 pages
Primorigen Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 17 pages
Momenta Pharmaceuticals, Inc. (MERT MTF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 27 pages
Mitsubishi Tanabe Pharma Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... subsidiary of Mitsubishi Chemical Holdings Corporation. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan. Mitsubishi Tanabe Pharma Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis ...

Apr, 2015 108 pages
Mertiva AB (MRK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 26 pages
Lumara Health Inc. (KVPHQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 33 pages
Lightlake Therapeutics Inc. (LLTPD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 20 pages
Les Laboratoires Servier SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... Les Laboratoires Servier SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings ...

Apr, 2015 102 pages
Idenix Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 38 pages
ICON plc (ICLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 37 pages
Heron Therapeutics, Inc. (HRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 29 pages
Healthways, Inc. (HWAY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile US$ 250.00

... deals database, and primary and secondary research. Scope Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year ...

Apr, 2015 18 pages
LifeScan, Inc. Market Share Analysis US$ 1,000.00

... , analysis and strategic insight into the medical equipment business of LifeScan, Inc.. The report provides key information relating to LifeScan, Inc. medical equipment revenue, market share by sector and country, financial and SWOT analysis of the ...

Nov, 2009 28 pages
Johnson and Johnson Vision Care, Inc Market Share Analysis US$ 1,000.00

... insight into the medical equipment business of Johnson & Johnson Vision Care, Inc.. The report provides key information relating to Johnson & Johnson Vision Care, Inc. medical equipment revenue, market ...

Nov, 2009 26 pages
Ethicon, Inc. Market Share Analysis US$ 1,000.00

... , analysis and strategic insight into the medical equipment business of Ethicon, Inc.. The report provides key information relating to Ethicon, Inc. medical equipment revenue, market share by sector and country, financial and SWOT analysis of the ...

Nov, 2009 115 pages
Trigeminal Neuralgia - Pipeline Review, H1 2016 US$ 2,000.00

Trigeminal Neuralgia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Trigeminal Neuralgia - Pipeline Review, H1 2016’, provides an overview of the Trigeminal Neuralgia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia ...

Mar, 2016 55 pages
Treventis Corporation - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Treventis Corporation’s pipeline products Reasons to buy Evaluate Treventis Corporation ...

Aug, 2014 22 pages
Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014’, provides an overview of the Sol-Gel Technologies Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sol-Gel Technologies Ltd ...

Aug, 2014 18 pages
NeoPharm Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the NeoPharm Co., Ltd.’s pipeline products Reasons to buy Evaluate NeoPharm Co., Ltd ...

Aug, 2014 31 pages
EyeCyte, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the EyeCyte, Inc.’s pipeline products Reasons to buy Evaluate EyeCyte, Inc ...

Aug, 2014 20 pages
Da Volterra - Product Pipeline Review - 2014 US$ 1,500.00

... Volterra - Product Pipeline Review - 2014’, provides an overview of the Da Volterra’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Da Volterra ...

Aug, 2014 21 pages
AllTranz, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AllTranz, Inc.’s pipeline products Reasons to buy Evaluate AllTranz, Inc ...

Aug, 2014 21 pages
vasopharm GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the vasopharm GmbH’s pipeline products Reasons to buy Evaluate vasopharm GmbH ...

Aug, 2014 22 pages
Tacere Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Tacere Therapeutics, Inc.’s pipeline products Reasons to buy Evaluate Tacere Therapeutics, Inc ...

Jul, 2014 27 pages
Phenomenome Discoveries, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Phenomenome Discoveries, Inc.’s pipeline products Reasons to buy Evaluate Phenomenome Discoveries, Inc ...

Jul, 2014 20 pages
Koronis Pharma, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Koronis Pharma, Inc.’s pipeline products Reasons to buy Evaluate Koronis Pharma, Inc ...

Aug, 2014 24 pages
Haemostatix Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Haemostatix Ltd’s pipeline products Reasons to buy Evaluate Haemostatix Ltd ...

Jul, 2014 20 pages
1 2 3 4 5 >
Skip to top